Burr et al.[47] identified CMTM6 as a critical regulator of PD-L1 in a broad range of cancer cells, and reported that CMTM6 is required for efficient endocytic recycling of PD-L1, thus preventing PD-L1 degradation in lysosomes. The gene discussed is CD274; the disease is cancer.